Inventor · disambiguated record
Marzia Monica Giuliani
Also filed as: GIULIANI MARZIA · GIULIANI MARZIA M · GIULIANI MARZIA MONICA
29 granted patents·20 pending applications·482 citations·filing 1989–2024
97Inventor score
Top patents by PatentIndex Score
49 records- 0196US8273360B2Outer membrane vesicle (OMV) vaccine comprising N. meningitidis serogroup B outer membrane proteinsPIZZA MARIAGRAZIA·Filed 2001·Granted Sep 25, 2012·74 cites·17 claims
- 0296US7862827B2Combination neisserial compositionsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2004·Granted Jan 4, 2011·57 cites·4 claims
- 0395US8398999B2Chimeric, hybrid and tandem polypeptides of meningococcal NMB1870MASIGNANI VEGA·Filed 2012·Granted Mar 19, 2013·29 cites·4 claims
- 0495US8226960B2Chimeric, hybrid and tandem polypeptides of meningococcal NMB1870MASIGNANI VEGA·Filed 2006·Granted Jul 24, 2012·28 cites·4 claims
- 0595US7291588B2Immunogenic detoxified mutant E. coli LT-A toxinCHIRON SRL·Filed 2002·Granted Nov 6, 2007·73 cites·10 claims
- 0695US7115730B1Immunogenic detoxified mutant E. coli LT-A-toxinCHIRON SRL·Filed 2000·Granted Oct 3, 2006·73 cites·26 claims
- 0794US9610342B2Combination neisserial compositionsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Granted Apr 4, 2017·10 cites·19 claims
- 0894US9150898B2Heterologous expression of Neisserial proteinsNOVARTIS AG·Filed 2014·Granted Oct 6, 2015·15 cites·12 claims
- 0993US9364528B1Combination neisserial compositionsGLAXOSMITHKLINE BIOLOG SA·Filed 2016·Granted Jun 14, 2016·8 cites·24 claims
- 1092US9267163B2Hybrid expression of neisserial proteinsARICÒ MARIA·Filed 2005·Granted Feb 23, 2016·20 cites·34 claims
- 1192US9156894B2Chimeric, hybrid and tandem polypeptides of meningococcal NMB1870NOVARTIS AG·Filed 2013·Granted Oct 13, 2015·14 cites·2 claims
- 1290US9468673B2Meningococcal fHBP polypeptidesNOVARTIS AG·Filed 2013·Granted Oct 18, 2016·6 cites·12 claims
- 1387US10195264B2Immunising against meningococcal serogroup Y using proteinsCONTORNI MARIO·Filed 2005·Granted Feb 5, 2019·11 cites·15 claims
- 1484US11707513B2Meningococcus vaccinesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2015·Granted Jul 25, 2023·3 cites·4 claims
- 1584US2025170232A1Vaccines for Neisseria GonorrhoeaeGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2024·Application pending·0 cites
- 1683US7700119B285kDa neisserial antigenNOVARTIS VACCINES & DIAGNOSTIC·Filed 2005·Granted Apr 20, 2010·6 cites·3 claims
- 1777US12485164B2Meningococcus vaccinesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2023·Granted Dec 2, 2025·0 cites·9 claims
- 1875US10598666B2In vitro potency assay for protein-based meningococcal vaccinesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2013·Granted Mar 24, 2020·2 cites·11 claims
- 1974US9579372B2Meningococcal fHBP polypeptidesPIZZA MARIAGRAZIA·Filed 2009·Granted Feb 28, 2017·1 cites·12 claims
- 2074US9057716B2Bactericidal antibody assays to assess immunogenicity and potency of meningococcal capsular saccharide vaccinesBALOCCHI CRISTIANA·Filed 2011·Granted Jun 16, 2015·7 cites·22 claims
- 2168US11209436B2Vitro potency assay for protein-based meningococcal vaccinesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2020·Granted Dec 28, 2021·0 cites·9 claims
- 2268US10376573B2Vaccines for serogroup X meningococcusGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2013·Granted Aug 13, 2019·3 cites·13 claims
- 2368US2022137051A1In-vitro potency assay for protein-based meningococcal vaccinesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2021·Application pending·0 cites
- 2467US12161707B2Vaccines for Neisseria gonorrhoeaeGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Granted Dec 10, 2024·0 cites·10 claims
- 2567US5130415ASynthetic peptide endowed with immunological activity, capable of inducing the production of antibodies with a high specificity towards alpha-fetoprotein, and their use in the diagnostic fieldSCLAVO SPA·Filed 1989·Granted Jul 14, 1992·21 cites·6 claims
- 2667US2015174231A1Combination neisserial compositionsNOVARTIS AG·Filed 2014·Application pending·0 cites
- 2765US9636393B2Compositions comprising Neisseria meningitidis antigens from serogroups B and CGIULIANI MARZIA MONICA·Filed 2000·Granted May 2, 2017·4 cites·7 claims
- 2865US8221761B1Enhancement of bactericidal activity of neisseria antigens with oligonucleotides containing CG motifsGRANDI GUIDO·Filed 2000·Granted Jul 17, 2012·2 cites·35 claims
- 2965US2017165346A1Combination neisserial compositionsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Application pending·0 cites
- 3065US2014294885A1Heterologous expression of neisserial proteinsNOVARTIS AG·Filed 2014·Application pending·0 cites
- 3165US2014037668A1Combination neisserial compositionsNOVARTIS AG·Filed 2013·Application pending·0 cites
- 3263US2017080076A1Heterologous expression of neisserial proteinsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Application pending·0 cites
- 3363US2017080077A1Heterologous expression of neisserial proteinsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Application pending·0 cites
- 3462US2005244436A1Combination Neisserial compositionsCHIRON SRL·Filed 2004·Application pending·0 cites
- 3559US2011104193A1Combination neisserial compositionsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2010·Application pending·0 cites
- 3658US2012328643A1Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteinsPIZZA MARIAGRAZIA·Filed 2012·Application pending·0 cites
- 3757US2011008279A1Methods and Compositions Relating to Adhesins as AdjuvantsMASIGNANI VEGA·Filed 2006·Application pending·0 cites
- 3857US2012135026A1Combination neisserial compositionsGIULIANI MARZIA MONICA·Filed 2012·Application pending·0 cites
- 3954US2016082098A1Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteinsGLAXOSMITHKLINE BIOLOG SA·Filed 2015·Application pending·0 cites
- 4053US2016030546A1Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteinsGLAXOSMITHKLINE BIOLOG SA·Filed 2015·Application pending·0 cites
- 4148US2010035234A1Vaccine assaysNOVARTIS AG·Filed 2009·Application pending·0 cites
- 4240US2009285845A1Domains And Epitopes Of Meningococcal Protein NMB1870MASIGNANI VEGA·Filed 2005·Application pending·0 cites
- 4339US6110705ARecombinant Chlamydia trachomatis pgp3 fusion proteinCHIRON SPA·Filed 1995·Granted Aug 29, 2000·5 cites·2 claims
- 4437US6096519AChlamydia trachomatis serotype D proteinsSCLAVO SPA·Filed 1997·Granted Aug 1, 2000·4 cites·2 claims
- 4537US2011076300A1Hybrid Polypeptides Including Meningococcal fHBP SequencesPIZZA MARIAGRAZIA·Filed 2010·Application pending·0 cites
- 4634US2012064103A1Combinations of meningococcal factor h binding protein and pneumococcal saccharide conjugatesGIULIANI MARZIA MONICA·Filed 2010·Application pending·0 cites
- 4731US6248563B1Chlamydia trachomatis serotype D genesSCALVO SPA·Filed 1995·Granted Jun 19, 2001·4 cites·9 claims
- 4831US2003113338A1Immunogenic detoxified mutant e. coli lt-a toxinFiled 1997·Application pending·0 cites
- 4926US5206164ADNA encoding a synthetic peptide endowed with immunological activity and capable of inducing the production of antibodies with a high specificity towards alpha-fetoproteinSCLAVO SPA·Filed 1992·Granted Apr 27, 1993·2 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Marzia Monica Giuliani files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →